Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies.
<h4>Background</h4>There is no consensus regarding whether androgen deprivation therapy (ADT) is associated with cardiovascular disease (CVD) and cardiovascular mortality (CVM). The objective of this study was to determine the role of ADT for prostate cancer (PCa) in development of cardi...
Guardado en:
Autores principales: | Jinsheng Zhao, Shimiao Zhu, Libin Sun, Fanzheng Meng, Lin Zhao, Yusheng Zhao, Hao Tian, Ping Li, Yuanjie Niu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6265110f975f4b87b51bca948d514168 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
por: Dominick G A Burton, et al.
Publicado: (2013) -
Efficacy and Prognostic Factors of Androgen Deprivation Therapy Combined with Radiation Therapy for Prostate Cancer
por: Siping Zeng, et al.
Publicado: (2021) -
Metabolic changes in patients with prostate cancer with androgen deprivation therapy
por: Maxim N. Peshkov, et al.
Publicado: (2020) -
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
por: Rolf Gedeborg, et al.
Publicado: (2021) -
Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
por: Mateus Bringel Oliveira Duarte, et al.
Publicado: (2021)